Skip to content
HowShorted

CHEMBIO DIAGNOSTICS, INC. short interest in 2020

In 2020, CHEMBIO DIAGNOSTICS, INC.'s disclosed short interest ran from 1.22% of shares outstanding on 15 Jan 2020 to 18.82% on 31 Dec 2020, a change of +17.60 percentage points. The year's high was 26.58% on 31 Jul 2020 and its low 1.22% on 15 Jan 2020, averaging 13.60% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 4.78 days on 14 Feb 2020. Full history: CHEMBIO DIAGNOSTICS, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023

Aggregate net short position time series for CHEMBIO DIAGNOSTICS, INC. in 2020

2020 in figures

Start of year
1.22% (15 Jan 2020)
End of year
18.82% (31 Dec 2020)
Change
+17.60 pp
High
26.58% (31 Jul 2020)
Low
1.22% (15 Jan 2020)
Average
13.60%
Highest days to cover
4.78 (14 Feb 2020)
SEC filings marked
9

Every report in 2020

CHEMBIO DIAGNOSTICS, INC. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 20201.22%1.36
31 Jan 20201.35%1.09
14 Feb 20201.55%4.78
28 Feb 20201.52%1.49
13 Mar 20201.77%1.0510-K filed, results (8-K)
31 Mar 20202.35%1.00
15 Apr 20203.87%1.00
30 Apr 20204.59%1.00
15 May 20205.40%1.0010-Q filed, results (8-K)
29 May 20208.05%1.51
15 Jun 202011.67%2.46
30 Jun 202017.33%1.00
15 Jul 202022.76%1.00results (8-K)
31 Jul 202026.58%1.09
14 Aug 202026.29%1.00results (8-K), 10-Q filed
31 Aug 202023.69%1.54
15 Sep 202021.26%2.21
30 Sep 202022.29%2.55
15 Oct 202022.68%1.48
30 Oct 202023.85%4.37
13 Nov 202020.52%3.5910-Q filed, results (8-K)
30 Nov 202017.87%3.19
15 Dec 202019.18%1.19
31 Dec 202018.82%4.17

See also: CHEMBIO DIAGNOSTICS, INC.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.